Education
About Us
Working with TipRanks
Follow Us
Quantum Genomics Societe Anonyme (FR:ALQGC)
:ALQGC
ALQGC Stock Chart & Stats
€0.07
€0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range€0.07 - €0.15
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
€5.03M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.89
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding69,709,950
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ALQGC FAQ
What was Quantum Genomics Societe Anonyme’s price range in the past 12 months?
Quantum Genomics Societe Anonyme lowest stock price was €0.07 and its highest was €0.15 in the past 12 months.
What is Quantum Genomics Societe Anonyme’s market cap?
Quantum Genomics Societe Anonyme’s market cap is €5.03M.
When is Quantum Genomics Societe Anonyme’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Quantum Genomics Societe Anonyme’s earnings last quarter?
Currently, no data Available
Is Quantum Genomics Societe Anonyme overvalued?
According to Wall Street analysts Quantum Genomics Societe Anonyme’s price is currently Undervalued.
Does Quantum Genomics Societe Anonyme pay dividends?
Quantum Genomics Societe Anonyme does not currently pay dividends.
What is Quantum Genomics Societe Anonyme’s EPS estimate?
Quantum Genomics Societe Anonyme’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quantum Genomics Societe Anonyme have?
Quantum Genomics Societe Anonyme has 69,709,950 shares outstanding.
What happened to Quantum Genomics Societe Anonyme’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Quantum Genomics Societe Anonyme?
Currently, no hedge funds are holding shares in FR:ALQGC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Quantum Genomics Societe Anonyme
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.